These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling. Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137 [TBL] [Abstract][Full Text] [Related]
8. TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1. Lee CS; Yi JS; Jung SY; Kim BW; Lee NR; Choo HJ; Jang SY; Han J; Chi SG; Park M; Lee JH; Ko YG Cell Death Differ; 2010 Aug; 17(8):1254-65. PubMed ID: 20139895 [TBL] [Abstract][Full Text] [Related]
9. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways. Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. Song YH; Godard M; Li Y; Richmond SR; Rosenthal N; Delafontaine P J Investig Med; 2005 Apr; 53(3):135-42. PubMed ID: 15921033 [TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism. Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461 [TBL] [Abstract][Full Text] [Related]
13. Calcineurin B homologous protein 3 negatively regulates cardiomyocyte hypertrophy via inhibition of glycogen synthase kinase 3 phosphorylation. Kobayashi S; Nakamura TY; Wakabayashi S J Mol Cell Cardiol; 2015 Jul; 84():133-42. PubMed ID: 25935310 [TBL] [Abstract][Full Text] [Related]
14. Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling. Bénard L; Oh JG; Cacheux M; Lee A; Nonnenmacher M; Matasic DS; Kohlbrenner E; Kho C; Pavoine C; Hajjar RJ; Hulot JS Circulation; 2016 Apr; 133(15):1458-71; discussion 1471. PubMed ID: 26936863 [TBL] [Abstract][Full Text] [Related]
15. Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes. Pentassuglia L; Heim P; Lebboukh S; Morandi C; Xu L; Brink M Am J Physiol Endocrinol Metab; 2016 May; 310(9):E782-94. PubMed ID: 26979522 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α. Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929 [TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling. Gao S; Duan C; Gao G; Wang X; Yang H Int J Biochem Cell Biol; 2015 Jul; 64():25-33. PubMed ID: 25813876 [TBL] [Abstract][Full Text] [Related]
19. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation. Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666 [TBL] [Abstract][Full Text] [Related]
20. HSP75 protects against cardiac hypertrophy and fibrosis. Zhang Y; Jiang DS; Yan L; Cheng KJ; Bian ZY; Lin GS J Cell Biochem; 2011 Jul; 112(7):1787-94. PubMed ID: 21381076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]